Bank of Montreal
GSK icon

Bank of Montreal’s GSK GSK Stock Holding History

Bank of Montreal’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-103,280
Closed -$6.9M – 4737
2014
Q1 		$6.9M Buy
+103,280
New +$6.98M 0.01% 812

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Bank of Montreal's GSK Position: Q2 2026 in Review

Bank of Montreal reduced its GSK (GSK) stake by 13% in Q2 2026, selling an estimated $31.6M and leaving 4,042,863 shares worth $212M. The position accounts for 0.07% of the portfolio, ranked #226.

Bank of Montreal first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $256M in Q1 2026. 749 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Bank of Montreal held 4,042,863 shares of GSK worth $212M as of Q2 2026.
  • Bank of Montreal sold 596,936 GSK shares in Q2 2026, an estimated $31.6M.
  • GSK made up 0.07% of Bank of Montreal's portfolio in Q2 2026, its #226 holding.
  • Bank of Montreal first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's GSK position peaked at $256M in Q1 2026.
  • 749 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.